Coronary Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age>=18 years old and=70% or 50-69%, and significant ischemia as assessed by CTA functional evaluation. Coronary intervention surgery is planned for treatment; 3. There is only one target lesion in the target vessel; 4. The patient and their family agree to participate in this clinical study and undergo regular postoperative follow-up, and sign a written informed consent form.
Exclusion criteria
Exclusion criteria: 1. There are contraindications for coronary angiography or coronary CTA, including known severe iodine contrast agent allergy, uncontrolled hyperthyroidism, pregnancy or lactation, high risk of contrast agent nephropathy, etc; 2. Hemodynamic or clinical instability, systolic blood pressure38mm, diameter>4mm, severe calcification, severe vessel distortion, bifurcation, and left main trunk lesions; 7. Poor quality of coronary CTA images affects diagnosis and subsequent functional evaluation (<=Likert level 3); 8. The patient is participating in another clinical study of a drug or medical device whose primary endpoint has not yet been evaluated.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The total time required for coronary intervention treatment of target lesions in a single vessel;Residual stenosis degree;Intraoperative complications; | — |
Secondary
| Measure | Time frame |
|---|---|
| Major adverse cardiovascularand cerebrovascular events (MACCE);In-stent restenosis;Fluoroscopy Time;Time required for stent implantation;The total cost of cardiovascular-related examinations upon admission; | — |
Countries
China
Contacts
Senior Department of Cardiology, the Sixth Medical Centre, Chinese PLA General Hospital